Cross-linked hyaluronic acid (XLHA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cross-linked hyaluronic acid (XLHA), covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis [NA]